London stocks ended higher on Wednesday, with investors maintaining a cautious yet positive stance ahead of Nvidia's earnings release in the United States later in the global day. The FTSE 100 index ...
(Alliance News) - CleanTech Lithium PLC on Wednesday said it now expects a delay to its listing on the Australian Securities Exchange, and announced that Tony Esplin, the group's chief executive ...
(Alliance News) - Strategic Equity Capital PLC on Wednesday said it saw an improved total return for the first half of its current financial year, markedly outperforming its benchmark index.
(Alliance News) - Avingtrans PLC on Wednesday reported higher revenue and profit for the first half of its financial year, maintaining confidence in meeting full-year market expectations. Shares in ...
(Alliance News) - BP PLC on Wednesday said it will slash renewable spending, up oil and gas investment as the company set out a plan to "fundamentally reset strategy".
Deutsche Bank Research starts 4imprint with 'buy' - price target 7,170 pence RBC cuts the Renewables Infrastructure target to 110 (115) p - 'outperform' Goldman Sachs raises Supermarket Income REIT ...
Aston Martin reported a pretax loss of GBP60.2 million in the quarter to December, swung from a GBP20.0 million profit a year prior. For 2024 as a whole, pretax loss was GBP289.1 million, widened from ...
Anglo Asian Mining PLC on Wednesday said it expects 2025 to be a "milestone" year for the firm, as it forecasts record copper and gold production. The Azerbaijan-focused gold, copper and silver miner ...
While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...
The London-based medical products and technologies company said pretax profit surged to USD245.9 million in 2024 from USD167.4 million the prior year, while revenue rose 6.9% to USD2.29 billion and ...
(Alliance News) - AstraZeneca PLC on Wednesday said its drug camizestrant significantly delayed disease progression in a phase III trial for advanced hormone receptor-positive breast cancer, ...
Looking ahead, Hikma projects revenue growth of 4% to 6% in 2025 and core operating profit in the range of USD730 million to USD770 million, in line with the USD751 million consensus at the mid-point, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results